---
schema_version: "secwatch.filing_event.v1"
accession: "0000950157-23-001058"
form_type: "8-K"
ticker: "TMO"
cik: "0000097745"
company_name: "THERMO FISHER SCIENTIFIC INC."
filed_at: "2023-10-17T23:59:59+00:00"
generated_at: "2026-06-09T23:02:39.228390+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Thermo Fisher to acquire Olink for $26/share, ~$3.1B total

## Summary
- Cash tender offer at $26/ADS, ~74% premium to Oct 16 close; transaction values Olink at ~$3.1B including ~$143M net cash.
- Expected close mid-2024; support agreements from >63% of Olink shareholders including largest shareholder Summa Equity.
- Olink projected >$200M revenue in 2024 with mid-teens organic growth; expected to be part of Thermo Fisher's Life Sciences Solutions segment.
- Transaction expected to be $0.17 dilutive to adjusted EPS in first full year, but $0.10 accretive excluding financing and equity comp.
- Thermo Fisher expects ~$125M adjusted operating income from synergies by year five.

## SEC filing metadata
- accession: 0000950157-23-001058
- form_type: 8-K
- ticker: TMO
- cik: 0000097745
- company_name: THERMO FISHER SCIENTIFIC INC.
- filed_at: 2023-10-17T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/97745/000095015723001058/0000950157-23-001058-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/97745/000095015723001058/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950157-23-001058
- JSON: https://secwatch.observer/filing/0000950157-23-001058.json
- Plain text: https://secwatch.observer/filing/0000950157-23-001058.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.